专利号:US-2008280855-A1 优先权日:2005-06-22 标 题 :Process For the Production of Intermediates For the Preparation of Tricyclic Benzimidazoles 发明人:CHIESA MARIA VITTORIA; PALMER ANDREAS; BUHR WILM; ZIMMERMANN PETER JAN; BREHM CHRISTOF; SIMON WOLFGANG-ALEXANDER; POSTIUS STEFAN; KROMER WOLFGANG; ZANOTTI-GEROSA ANTONIO 权利人:NYCOMED GMBH 摘要:The invention relates to a process for the synthesis of compounds of the formula 1-a and compounds of the formula 1-b. n n n n n n n n n n The compounds of the formula 1-a and the compounds of the formula 1-b, in which the substituents R1, R2, R3, and Ar have the meanings indicated in the description, are valuable intermediates for the preparation of pharmaceutically active compounds.
专利号:WO-02088088-A9 优先权日:2001-04-27 标题 :Process for preparing 1-methyl-1,2,3,4-tetrahydroisoquinoline or a salt thereof 发明人:BREEN GARY FRANCIS; FORTH MICHAEL ANTHONY; POPKIN MATTHEW EDWARD 权利人:SB PHARMCO INC; BREEN GARY FRANCIS; FORTH MICHAEL ANTHONY; POPKIN MATTHEW EDWARD 摘要:The invention provides a process for preparing 1-methyl-1,2,3,4-tetrahydroisoquinoline of formula (A), or a salt thereof, the process comprising: (i) reacting N-(2-chloroethyl)-α-methylbenzylamine of formula (B), or a salt thereof, with a Lewis acid such as AlCl3, and (ii) causing or allowing cyclisation to 1-methyl-1,2,3,4-tetrahydroisoquinoline. The invention also provides a process for preparing 1-methyl-1,2,3,4-tetrahydroisoquinoline of formula (A), or a salt thereof, the process comprising: (i) reacting a N-(2-haloethyl)-α-methylbenzylamine, or a salt thereof, with a Lewis acid and (ii) causing or allowing cyclisation to 1-methyl-1,2,3,4-tetrahydroisoquinoline at a temperature of ≤130°C. The use of N-(2-chloroethyl)-α-methylbenzylamine and/or lower cyclisation temperatures decreases the amount of certain impurities formed in the reaction. In other aspects of the invention, the 1-methyl-1,2,3,4-tetrahydroisoquinoline can be used in the synthesis of 5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine (SB 641257, YH1885), a pharmaceutically active reversible proton pump inhibitor.
专利号:CN-114616340-A 优先权日:2019-07-09 标题 :Process for the synthesis of anticoagulant polysaccharides
专利号:CN-118978468-A 优先权日:2024-07-31 标 题 :Synthesis method of voronoi fumarate intermediate
专利号:CN-119798142-A 优先权日:2025-01-15 标 题 :Asymmetric catalytic synthesis method of chiral 3-aminopiperidine and derivative thereof
1: Kim JH, Kim EH, Ock C, Hong H, Kim YJ, Kwon KA, Park DK, Hahm KB. Mitigating endoplasmic reticulum stress with revaprazan ameliorates stress-related mucosal disease. J Gastroenterol Hepatol. 2012 Jan;27(1):120-9. doi: 10.1111/j.1440-1746.2011.06838.x. doi: 10.5009/gnl14135. 3: Choi HY, Noh YH, Jin SJ, Kim YH, Kim MJ, Sung H, Jang SB, Lee SJ, Bae KS, Lim HS. Bioavailability and tolerability of combination treatment with revaprazan 200 mg + itopride 150 mg: a randomized crossover study in healthy male Korean volunteers. Clin Ther. 2012 Sep;34(9):1999-2010. doi: 10.1016/j.clinthera.2012.07.004. Epub 2012 Aug 1. Korean. doi: 10.3164/jcbn.11-94. Epub 2012 Jul 20. 7: Park SY. [Effect of acid pump antagonist (Revaprazan, Revanex(R)) on the result of 13C urea breath test in the patients with Helicobacter pylori associated peptic ulcer disease]. Korean J Gastroenterol. 2011 Jan;57(1):1-2. Korean. doi: 10.1016/j.ijpharm.2011.01.059. Epub 2011 Feb 2. doi: 10.1159/000339882. Epub 2012 Aug 14.
合成参考文献
摘要:S92 | FLUOROPHARMA | List of ~340 ATC classified fluoro-pharmaceuticals | DOI:10.5281/zenodo.5979646